GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MeCure Industries Plc (NSA:MECURE) » Definitions » Current Accrued Expense

MeCure Industries (NSA:MECURE) Current Accrued Expense : ₦0.00 Mil (As of . 20)


View and export this data going back to 2023. Start your Free Trial

What is MeCure Industries Current Accrued Expense?

MeCure Industries's Current Accrued Expense for the quarter that ended in . 20 was ₦0.00 Mil.


MeCure Industries Current Accrued Expense Historical Data

The historical data trend for MeCure Industries's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MeCure Industries Current Accrued Expense Chart

MeCure Industries Annual Data
Trend
Current Accrued Expense

MeCure Industries Semi-Annual Data
Current Accrued Expense

MeCure Industries Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


MeCure Industries Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of MeCure Industries's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


MeCure Industries Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Apapa Oshodi Expressway, Me Cure House, Plot 6, Block H, Oshodi, Lagos, NGA
MeCure Industries Plc is a therapeutics company in the pharmaceutical industry in Lagos, Nigeria. It is principally engaged in the business of manufacturing drugs (tablets, capsules, and syrups) in Nigeria and consists of two categories namely Pharmaceuticals and Nutraceuticals. The Pharmaceuticals segment comprises forty-one (41) drugs such as Ebu 200 & 400 (ibuprofen tablets), Laclox (an anilox formulation), Lamox (an amoxicillin formulation), and Lampicin (an ampicillin formulation), used in treating different ailments. The Nutraceuticals segment consists of 100 products including multivitamins and dietary supplements.

MeCure Industries Headlines

No Headlines